Summary: Thought Leader: Rodeina Challand, Executive Director, Biosimilars Development, PRA International In this episode, Rodeina Challand clears up some of the murkiness among the many terms associated with biosimilars. Then, we cover the legislation and guidelines affecting biosimilars, we discuss the possibilities of one global program, and finally talk about the future for a global standard. For more information about PRA International, visit www.prainternational.com. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
